Michael K. Templin
Directeur Financier/CFO chez ABT Molecular Imaging, Inc.
Profil
Michael K.
Templin is currently the Chief Financial Officer & Vice President-Finance at ABT Molecular Imaging, Inc. He previously held the same position at CTI Molecular Imaging, Inc. and worked as an Audit Manager at Coopers & Lybrand LLP.
He received his undergraduate degree and MBA from the University of Tennessee.
Postes actifs de Michael K. Templin
| Sociétés | Poste | Début |
|---|---|---|
ABT Molecular Imaging, Inc.
 ABT Molecular Imaging, Inc. BiotechnologyHealth Technology ABT Molecular Imaging, Inc. develops a production platform to generate unit doses of molecular imaging drugs. It markets the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography at the point of use. The company was founded by Ronald Nutt and Lynda J. Nutt in 2006 and is headquartered in Louisville, TN. | Directeur Financier/CFO | 01/02/2013 |
Anciens postes connus de Michael K. Templin
| Sociétés | Poste | Fin |
|---|---|---|
| Coopers & Lybrand LLP | Corporate Officer/Principal | - |
CTI Molecular Imaging, Inc.
 CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | Directeur Financier/CFO | - |
Formation de Michael K. Templin
| University of Tennessee | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ABT Molecular Imaging, Inc.
ABT Molecular Imaging, Inc. BiotechnologyHealth Technology ABT Molecular Imaging, Inc. develops a production platform to generate unit doses of molecular imaging drugs. It markets the BG-75 Biomarker Generator, which produces unit doses of molecular imaging drugs for positron emission tomography at the point of use. The company was founded by Ronald Nutt and Lynda J. Nutt in 2006 and is headquartered in Louisville, TN. | Health Technology |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
